Neuroprotective peptide therapies are emerging as promising treatments for stroke and brain injuries. These therapies focus on using specific peptides, particularly those rich in arginine ...
Reid, hereinafter “PeptiDream”) (Tokyo:4587) today announced its second wholly-owned peptide radiopharmaceutical development candidate arising from the company’s ongoing internal peptide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback